Letters Are selective COX 2 inhibitors superior to traditional NSAIDs? BMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7356.161 (Published 20 July 2002) Cite this as: BMJ 2002;325:161 Article Related content Metrics Responses Peer review Related articles Editor's Choice Big trials and human stories Published: 20 July 2002; BMJ 325 doi:10.1136/bmj.325.7356.0/i See more Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis BMJ December 05, 2016, 355 i6188; DOI: https://doi.org/10.1136/bmj.i6188 Proton pump inhibitors and community acquired pneumonia BMJ November 17, 2016, 355 i6041; DOI: https://doi.org/10.1136/bmj.i6041 NSAIDs and the failing heart BMJ September 28, 2016, 354 i5163; DOI: https://doi.org/10.1136/bmj.i5163 Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study BMJ September 28, 2016, 354 i4857; DOI: https://doi.org/10.1136/bmj.i4857 Data feedback and behavioural change intervention to improve primary care prescribing safety (EFIPPS): multicentre, three arm, cluster randomised controlled trial BMJ August 18, 2016, 354 i4079; DOI: https://doi.org/10.1136/bmj.i4079
